Relapsed and Refractory Hepatoblastoma: A Prospective Registry and Liver Tumor Research Consortium Initiative

Part of paid clinical trials in Cincinnati, Ohio.

Sponsor
Children's Hospital Medical Center, Cincinnati
Study ID
NCT05556642
Status
Recruiting
Apply to this trial

Conditions

  • Refractory Hepatoblastoma
  • Relapsed Hepatoblastoma

Eligibility Criteria

Sex
ALL
Age
N/A - N/A
Healthy Volunteers
Not accepted

Interventions

  • Biospecimen collection — OTHER
    Clinical information and biospecimens will be collected

Study Details

There are limited data regarding the biology and treatment of relapsed/refractory hepatoblastoma (rrHBL). This project provides the infrastructure for acquisition of biological specimens, imaging, and correlative clinical data to facilitate biology studies and characterization of rrHBL. This registry will collect clinical, demographic, and pathological data, specimens (as available) and imaging from patients with rrHBL, prospectively. Cases are identified through: 1. Existing clinical and/or cancer registry databases 2. Referrals from clinicians, surgeons, or pathologists 3. Families initiating contact with Registry staff directly

Key Dates

Start date
Sep 7, 2022
Status verified
Mar 2026
Primary completion
Sep 1, 2032
Completion
Sep 1, 2040

Study Design

Enrollment
500 participants (estimated)

Arms

  • Arm: Group 1
    Patients with relapsed/ refractory Hepatoblastoma

Primary Outcome Measure

Characterization of relapsed or refractory Hepatoblastoma [ Time Frame: From enrollment until data analysis is complete - assessed up to 40 years ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
Cincinnati Children's Hospital Medical CenterCincinnatiOhio45229-

Find similar trials in Cincinnati, OH

By research site
Cincinnati Children's Hospital Medical Center· Cincinnati, OH

Related Studies